Servier India, the Indian arm of the French pharmaceutical group Servier, has launched a patient-centric biomarker testing ...

Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening ...

Researchers at the US Centers for Disease Control and Prevention (CDC) have identified a few instances of asymptomatic human ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

REDx™FLOQ® is a trademark of Microbix Biosystems Inc. in collaboration with Copan Italia S.p.A. FLOQ® is a trademark of Copan ...

Servier India, a subsidiary of the leading French pharmaceutical company Servier Group, has joined hands with genomic ...

Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due ...

Molecular and genetic testing has become a game-changer in brain tumour care - shaping diagnosis, guiding treatments and opening doors to new therapies.

Two critical but expensive genetic tests that guide treatment for an aggressive blood cancer and a rare bile duct cancer will ...

Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November ...

Professor Oliver Bathe examines how a new molecular test can lead to smarter decisions and better patient care outcomes in his third article ...

Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.